| Price | 209.00p on 08-10-2026 at 15:35:17 |
|---|---|
| Change | -13.00p -5.86% |
| Buy | 209.00p |
| Sell | 206.00p |
| Last Trade: | Buy 37.00 at 209.00p |
| Day's Volume: | 26,359 |
| Last Close: | 209.00p |
| Open: | 211.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 206.00p - 211.00p |
| 52wk Range: | 153.00p - 241.00p |
| Market Capitalisation: | £1.82b |
| VWAP: | 208.65084p |
| Shares in Issue: | 869.07m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 37 | 209.00p | Suspected BUY Trade |
16:35:04 - 08-Oct-26 |
| Sell* | 133 | 206.00p | Automatic Execution |
16:19:08 - 08-Oct-26 |
| Sell* | 1 | 206.10p | Ordinary |
15:55:11 - 08-Oct-26 |
| Buy* | 4 | 210.60p | Ordinary |
15:14:01 - 08-Oct-26 |
| Sell* | 160 | 207.00p | Automatic Execution |
12:10:21 - 08-Oct-26 |
| Sell* | 2,463 | 207.00p | Automatic Execution |
12:10:21 - 08-Oct-26 |
| Sell* | 5,830 | 207.00p | Ordinary |
12:09:44 - 08-Oct-26 |
| Sell* | 1,000 | 211.10p | Ordinary |
10:46:10 - 08-Oct-26 |
| Sell* | 13 | 208.00p | Automatic Execution |
08:55:40 - 08-Oct-26 |
| Sell* | 1,500 | 208.00p | Automatic Execution |
08:55:40 - 08-Oct-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Sep 2026 7:00 am | RNS-R | Submission of US NDA for ORPATHYS® plus TAGRISSO |
| 28th Sep 2026 7:00 am | RNS-R | HUTCHMED Initiates Global Trial of HMPL-A830 |
| 24th Sep 2026 7:00 am | RNS-R | Data to be Presented at ESMO 2026 |
| 3rd Sep 2026 7:00 am | RNS | HUTCHMED Licenses KRAS-EGFR-Antibody to GSK |
| 1st Sep 2026 7:00 am | RNS | SANOVO trial demonstrated significant PFS benefit |
| 28th Aug 2026 7:00 am | RNS | NMPA Approval for ATLED® (Fanregratinib) for ICC |
| 18th Aug 2026 10:00 am | RNS | Announcement pursuant to AIM Rule 17 Schedule 2(g) |
| 17th Aug 2026 7:00 am | RNS | Orpathys+Tagrisso improved PFS & OS in EGFRm lung |
| 30th Jul 2026 12:00 pm | RNS | HUTCHMED Reports 2026 Interim Results |
| 2nd Jul 2026 9:30 am | RNS | HUTCHMED Announces NMPA Approval for ORPATHYS |
